Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.
UNLABELLED: Transient cognitive and behavioral stabilization of patients with Alzheimer's disease (AD) is the main goal of long-term acetylcholinesterase inhibitor (AChEI) therapy, but response to treatment is variable and, indeed, only some of the patients are stabilized. This is usually asse...
Egile Nagusiak: | Nobili, F, Koulibaly, M, Vitali, P, Migneco, O, Mariani, G, Ebmeier, K, Pupi, A, Robert, P, Rodriguez, G, Darcourt, J |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2002
|
Antzeko izenburuak
-
Automatic classification of SPECT images of Alzheimer's disease patients and control subjects
nork: Stoeckel, J, et al.
Argitaratua: (2004) -
Using SPM as a diagnostic help with HMPAO-SPECT in Alzheimer's disease
nork: Ebmeier, K, et al.
Argitaratua: (2001) -
Human brain acetylcholinesterase
nork: Novales-Li, P
Argitaratua: (1993) -
Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
nork: Appleyard, M, et al.
Argitaratua: (1983) -
Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.
nork: Ebmeier, K, et al.
Argitaratua: (1992)